ClinicalTrials.gg
Drug

Liposomal Mitoxantrone Hydrochloride clinical trials

Also written HE071.

A product of Mitoxantrone; its studies count on that page too.

studies test it
34
open now
10
in phase 3
1
first study started
2011

How each study uses Liposomal Mitoxantrone Hydrochloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Liposomal Mitoxantrone Hydrochloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 1987 · NOVANTRONE · NDA 019297 (FDA, Drugs@FDA; as Mitoxantrone)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mitoxantrone Hydrochloride Liposome Injection
14
Mitoxantrone Hydrochloride Liposome
11
Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
3

Development codes

HE071
2

Studies by the year they started

34 studies that test it; most in 2021 (9)

Studies that test Liposomal Mitoxantrone Hydrochloride, by start year
YearStudies
20111
20131
20151
20161
20181
20191
20202
20219
20226
20235
20245
20261

By phase

A phase 1/2 study counts in both.

Phase 1
16
Phase 2
16
Phase 3
1
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 12

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (20) · The First Affiliated Hospital with Nanjing Medical University (3) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Institute of Hematology & Blood Diseases Hospital, China (2) · Sun Yat-sen University (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · The First Hospital of Jilin University (1) · Children's Hospital of Soochow University (1)

Often tested with

Tested in the same studies.

Vincristine (5) · Rituximab (4) · Etoposide (3) · Cyclophosphamide (3) · Irinotecan (2) · Ifosfamide (2) · Venetoclax (2) · Prednisone (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test Liposomal Mitoxantrone Hydrochloride.

Studies

Open first, then newest update. How each study uses Liposomal Mitoxantrone Hydrochloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test Liposomal Mitoxantrone Hydrochloride →

Given beside what is tested · 20 — Liposomal Mitoxantrone Hydrochloride is usual care or a partner of the new treatment